
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5342EE8AF3F7C30542EE0039CC4D38.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="springeropen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Acta Neuropathologica">
<meta name="citation_title" content="DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma">
<meta name="citation_author" content="Katharina Johanna Weber">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Heinrich-Hoffmann-Straße 7, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author_institution" content="German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany">
<meta name="citation_author_institution" content="Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany">
<meta name="citation_author" content="Mareike Dettki">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Marco Münzberg">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Heinrich-Hoffmann-Straße 7, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Pia Susann Zeiner">
<meta name="citation_author_institution" content="German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany">
<meta name="citation_author_institution" content="Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Department of Neurology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Marie-Thérèse Forster">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Eike Steidl">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Institute of Neuroradiology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Iris Divé">
<meta name="citation_author_institution" content="German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany">
<meta name="citation_author_institution" content="Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany">
<meta name="citation_author_institution" content="Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany">
<meta name="citation_author" content="Patrick Nikolaus Harter">
<meta name="citation_author_institution" content="German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany">
<meta name="citation_author_institution" content="Center for Neuropathology and Prion Research, Faculty of Medicine, Ludwig Maximilians University Munich, University Hospital, Feodor-Lynen-Straße 23, 81377 Munich, Germany">
<meta name="citation_author_institution" content="Bayerisches Zentrum Für Krebsforschung (BZKF), Partner Site Munich, Marchioninistraße 15, 81377 Munich, Germany">
<meta name="citation_author_institution" content="University Hospital, Ludwig Maximilians University Munich, Geschwister-Scholl-Platz 1, 80539 Munich, Germany">
<meta name="citation_author" content="Michael Scherer">
<meta name="citation_author_institution" content="Divison of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="150">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="21">
<meta name="citation_doi" content="10.1007/s00401-025-02926-y">
<meta name="citation_pmid" content="40849395">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/pdf/401_2025_Article_2926.pdf">
<meta name="description" content="IDH-mutant gliomas represent a subtype of diffuse gliomas that primarily affect patients in early to mid-adolescence. These tumors are classified into three distinct CNS WHO grades of malignancy. Accurate grading is essential for selecting an ...">
<meta name="og:title" content="DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="IDH-mutant gliomas represent a subtype of diffuse gliomas that primarily affect patients in early to mid-adolescence. These tumors are classified into three distinct CNS WHO grades of malignancy. Accurate grading is essential for selecting an ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374884">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s00401-025-02926-y"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/401_2025_Article_2926.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374884%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374884/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374884/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-springeropen.png" alt="Springer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Springer" title="Link to Springer" shape="default" href="https://doi.org/10.1007/s00401-025-02926-y" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Acta Neuropathol</button></div>. 2025 Aug 23;150(1):21. doi: <a href="https://doi.org/10.1007/s00401-025-02926-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s00401-025-02926-y</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Acta%20Neuropathol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acta%20Neuropathol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Acta%20Neuropathol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Acta%20Neuropathol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weber%20KJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Katharina Johanna Weber</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Katharina Johanna Weber</span></h3>
<div class="p">
<sup>1</sup>Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Heinrich-Hoffmann-Straße 7, 60528 Frankfurt Am Main, Germany </div>
<div class="p">
<sup>2</sup>German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany </div>
<div class="p">
<sup>3</sup>Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany </div>
<div class="p">
<sup>4</sup>Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weber%20KJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Katharina Johanna Weber</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dettki%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mareike Dettki</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mareike Dettki</span></h3>
<div class="p">
<sup>5</sup>Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dettki%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mareike Dettki</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCnzberg%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Marco Münzberg</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Marco Münzberg</span></h3>
<div class="p">
<sup>1</sup>Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Heinrich-Hoffmann-Straße 7, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCnzberg%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marco Münzberg</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeiner%20PS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Pia Susann Zeiner</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Pia Susann Zeiner</span></h3>
<div class="p">
<sup>2</sup>German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany </div>
<div class="p">
<sup>3</sup>Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany </div>
<div class="p">
<sup>4</sup>Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany </div>
<div class="p">
<sup>5</sup>Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">
<sup>6</sup>Goethe University Frankfurt, University Hospital, Department of Neurology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeiner%20PS%22%5BAuthor%5D" class="usa-link"><span class="name western">Pia Susann Zeiner</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Forster%20MT%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Marie-Thérèse Forster</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Marie-Thérèse Forster</span></h3>
<div class="p">
<sup>7</sup>Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Forster%20MT%22%5BAuthor%5D" class="usa-link"><span class="name western">Marie-Thérèse Forster</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steidl%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Eike Steidl</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Eike Steidl</span></h3>
<div class="p">
<sup>8</sup>Goethe University Frankfurt, University Hospital, Institute of Neuroradiology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steidl%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eike Steidl</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Div%C3%A9%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Iris Divé</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Iris Divé</span></h3>
<div class="p">
<sup>2</sup>German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany </div>
<div class="p">
<sup>3</sup>Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany </div>
<div class="p">
<sup>4</sup>Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany </div>
<div class="p">
<sup>5</sup>Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Div%C3%A9%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Iris Divé</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harter%20PN%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Patrick Nikolaus Harter</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Patrick Nikolaus Harter</span></h3>
<div class="p">
<sup>9</sup>German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany </div>
<div class="p">
<sup>10</sup>Center for Neuropathology and Prion Research, Faculty of Medicine, Ludwig Maximilians University Munich, University Hospital, Feodor-Lynen-Straße 23, 81377 Munich, Germany </div>
<div class="p">
<sup>11</sup>Bayerisches Zentrum Für Krebsforschung (BZKF), Partner Site Munich, Marchioninistraße 15, 81377 Munich, Germany </div>
<div class="p">
<sup>12</sup>University Hospital, Ludwig Maximilians University Munich, Geschwister-Scholl-Platz 1, 80539 Munich, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harter%20PN%22%5BAuthor%5D" class="usa-link"><span class="name western">Patrick Nikolaus Harter</span></a>
</div>
</div>
<sup>9,</sup><sup>10,</sup><sup>11,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scherer%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Michael Scherer</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Michael Scherer</span></h3>
<div class="p">
<sup>13</sup>Divison of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scherer%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael Scherer</span></a>
</div>
</div>
<sup>13</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Heinrich-Hoffmann-Straße 7, 60528 Frankfurt Am Main, Germany </div>
<div id="Aff2">
<sup>2</sup>German Cancer Consortium (DKTK), Germany and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg, 69120 Germany </div>
<div id="Aff3">
<sup>3</sup>Frankfurt Cancer Institute (FCI), Paul-Ehrlich-Str. 42-44, 60596 Frankfurt Am Main, Germany </div>
<div id="Aff4">
<sup>4</sup>Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany </div>
<div id="Aff5">
<sup>5</sup>Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div id="Aff6">
<sup>6</sup>Goethe University Frankfurt, University Hospital, Department of Neurology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div id="Aff7">
<sup>7</sup>Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div id="Aff8">
<sup>8</sup>Goethe University Frankfurt, University Hospital, Institute of Neuroradiology, Schleusenweg 2-16, 60528 Frankfurt Am Main, Germany </div>
<div id="Aff9">
<sup>9</sup>German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany </div>
<div id="Aff10">
<sup>10</sup>Center for Neuropathology and Prion Research, Faculty of Medicine, Ludwig Maximilians University Munich, University Hospital, Feodor-Lynen-Straße 23, 81377 Munich, Germany </div>
<div id="Aff11">
<sup>11</sup>Bayerisches Zentrum Für Krebsforschung (BZKF), Partner Site Munich, Marchioninistraße 15, 81377 Munich, Germany </div>
<div id="Aff12">
<sup>12</sup>University Hospital, Ludwig Maximilians University Munich, Geschwister-Scholl-Platz 1, 80539 Munich, Germany </div>
<div id="Aff13">
<sup>13</sup>Divison of Cancer Epigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 20; Revised 2025 Jul 18; Accepted 2025 Aug 11; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374884  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849395/" class="usa-link">40849395</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">IDH-mutant gliomas represent a subtype of diffuse gliomas that primarily affect patients in early to mid-adolescence. These tumors are classified into three distinct CNS WHO grades of malignancy. Accurate grading is essential for selecting an appropriate treatment maximizing anti-tumor efficacy while minimizing adverse effects. However, grading of oligodendrogliomas with 1p/19q codeletion currently relies on qualitative tumor characteristics that may be influenced by observer subjectivity, sampling bias, and tumor heterogeneity. This study aimed to explore DNA methylation-based tumor deconvolution into latent methylation components (LMCs) to evaluate their potential as objective grading tools in a cohort of 137 IDH-mutant gliomas. LMCs were analyzed in relation to malignancy markers, cellular composition, and underlying methylation signatures of the chromatin landscape. Glioma subtypes were associated with distinct LMCs. Two LMCs correlated with higher cellular density and advanced epigenetic age as well as with microvascular proliferation, necrosis, and epigenetically defined high-grade astrocytoma. The epigenetic patterns defining high-grade astrocytoma or oligodendroglioma, respectively, were similar. Higher-grade oligodendrogliomas, identified by LMC-based grading, were associated with more copy number alterations. Among patients of an external cohort who died during the assessment period, higher LMC1 proportions were associated with poorer overall survival. Therefore, LMCs hold the potential to support IDH-mutant glioma grading by incorporating objective epigenetic markers.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s00401-025-02926-y.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> IDH mutant glioma, Epigenetic brain tumor classification, Latent methylation component, CNS WHO grading, Oligodendroglioma</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Isocitrate dehydrogenase mutant (IDHmt) gliomas belong to adult-type diffuse gliomas and display an average annual age-adjusted incident rate of 0.74/100.000 [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Codeleted oligodendroglioma can be distinguished from non-codeleted astrocytoma based on aberrations of chromosomal arms 1p and 19q [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. According to the classification of central nervous system (CNS) tumors by the WHO, the highest CNS WHO grade, 4, is assigned to astrocytomas with a homozygous deletion of the cell cycle checkpoint <em>CDKN2A/B</em>, tumor necrosis, or microvascular proliferation [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Neuropathological grading of lower-grade astrocytomas and oligodendrogliomas in general is more challenging, especially since definitive molecular features are lacking. Whereas astrocytomas without clear features of malignancy but increased mitotic activity, marked nuclear pleomorphism, or high cellular density are graded as CNS WHO 3, grade 2 astrocytoma lacks pleomorphism, brisk mitotic figures, and increased cellularity [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. With these qualitative histological traits, the boundaries between the assignment of lower grades can be blurred and observer dependent. For oligodendroglioma, of which CNS WHO grade 2 and 3 are recognized, grading is even more demanding [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. While higher cellularity and marked nuclear atypia are majorly found in higher-grade oligodendroglioma, the presence of microvascular proliferation and/or necrosis is not strictly considered as criteria for CNS WHO grade 3 [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Prior studies provided evidence that homozygous deletion of <em>CDKN2A/B</em>, the presence of chromosomal aberrations other than 1p/19q-codeletion, and a brisk mitotic frequency higher than 2.5 mitoses/mm<sup>2</sup> might be associated with higher-grade tumors [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. From an epidemiological perspective, two age peaks of oligodendroglioma incidence were observed and increased age at first diagnosis was reported as a reliable prognostic factor for lower survival probability [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Cellular aging can be inferred from changes in DNA methylation patterns rendering estimates of an “epigenetic age” in comparison to chronological age [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Since accelerated epigenetic aging of tumors was associated with 1p/19q-codeletion and a survival benefit for patients suffering from glioblastoma, IDH wildtype, its potential as a prognostic biomarker in gliomas warrants further investigation [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par3">IDH mutant gliomas harbor distinct epigenetic alterations, including global DNA hypermethylation through the inhibition of TET demethylases, which is orchestrated via the production of the mutation-induced oncoprotein 2-HG [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. The increased level of DNA methylation at CpG islands—genomic regions regulating gene expression at promoters—coined the terminology of G-CIMP, Glioma CpG Island Methylator Phenotype [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. An important milestone was the development of a DNA-methylation based classifier of brain tumors, which improved diagnostic accuracy [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Albeit astrocytomas can be differentiated into “astrocytoma” and “high-grade astrocytoma” based on this classifier, this epigenetic graduation is not clearly associated with CNS WHO grades [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. For oligodendroglioma, furthermore, the brain tumor classifier recognizes one methylation class only without a distinction between higher- and lower-grade methylation signatures. Since DNA methylation-based profiling of primary brain tumors is comprehensively used in diagnostics, the exploration of epigenetic alterations which corroborate CNS WHO grading is very appealing [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. While recent studies contributed to the refined classification of astrocytomas based on DNA methylation profiles, similar approaches have not been leveraged for oligodendroglioma [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Since neuro-oncological patient treatment demands optimized chemotherapeutic strategies, and the clinical use of most recently accessible molecular compounds is restricted to lower-grade gliomas, it is important to further understand malignant transition and to define the CNS WHO grades more precisely [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par4">Therefore, we set out for an observer-independent, in-depth investigation of DNA methylation signatures of IDH mutant gliomas using reference-free deconvolution [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. We show that Latent Methylation Components (LMCs) are associated with glioma subtypes, histologic tumor characteristics, and CNS WHO grades. Focusing on oligodendroglioma, we propose an LMC-based grading, which coalesced with increased chromosomal aberrations and improved the stratification of oligodendroglioma patients in the low-grade glioma cohort provided by the Cancer Genome Atlas (TCGA).</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Collection of epidemiological, molecular and neuro-radiological data</h3>
<p id="Par5">Patients treated at the tertiary center for neuro-oncology of the University Hospital Frankfurt for epigenetically classified IDH mutant glioma between 2016 and 2022 were enrolled. Electronic patient records were screened for sex, age at diagnosis, Karnofsky Performance Score (KPS) prior to surgery, extent of resection, and therapy regimen. The MRI scans prior to surgery were reviewed for contrast agent enrichment in the tumors by a trained neuro-radiologist (ES). Patients treated with inhibitors targeting mutant IDH were not included in this study. DNA methylation classes were obtained using the Heidelberg (HD) brain tumor classifier by uploading DNA methylation data onto molecularneuropathology.org. We obtained calibrated scores (v11b4 and v12.5) and MGMT promoter methylation status for each tumor (© MolecularNeuroPathology.org 2023). In addition, visual copy number analyses for assessment of 1p/19q-codeletion status as well as homozygous deletion of the gene locus <em>CDKN2A/B</em> were performed based on methylation data. If the estimated copy number profile at the <em>CDKN2A/B</em> gene locus was lower than a single chromosomal loss (i.e., a copy number change of 1), a homozygous deletion was assumed [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Otherwise, if a drop in the copy number profile was detected for <em>CDKN2A/B</em> in 1p/19q-codeleted tumors that did not reach the manual threshold of a homozygous deletion, the deletion was classified as heterozygous [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The tumors were classified according to the 5th edition of the WHO classification of Central Nervous System Tumors [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. The study was approved by the local ethical committee (SNO-4–2023).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Histology and immunohistochemistry</h3>
<p id="Par6">4 µm-thick tissue sections of Formalin-fixed paraffin-embedded tumor tissue were cut using a microtome (Leica SM 2000R, Germany), mounted on slides (Superfrost Plus, Thermo Scientific, Germany) and stained according to manual H&amp;E routine staining protocols. For samples not originating from stereotaxic biopsy, the H&amp;E slides were evaluated for presence of tumor necroses and microvascular proliferation as well as maximum cellular density using the categories low, intermediate, and high. The mitotic frequency was raised on whole mount H&amp;E stains by careful microscopic analysis of 3 × 10 high power fields and documentation of the highest number of mitotic figures per mm<sup>2</sup>. The immunohistochemical Ki67 staining was performed using the LEICA BOND-III automated stainer (Leica, Wetzlar, Germany) following established protocols (MIB-1, dilution 1:200; DAKO; Glostrup, Denmark). An integrative Ki67-proliferation score was assigned to each whole mount tumor sample. All slides were examined by a board-certified neuropathologist (KJW) using a brightfield microscope (model BX51, field of view 22mm, Olympus; Tokyo, Japan).</p></section><section id="Sec5"><h3 class="pmc_sec_title">DNA methylation analyses</h3>
<p id="Par7">DNA from punch biopsies of FFPE tissue was extracted using either the Stratek Invisorb Genomic DNA Kit II (stratek molecular, Berlin, Germany) or the Maxwell RSC FFPE Plus DNA Kit (Promega, Madison, Wisconsin, USA) following the manufacturer protocols at the Edinger Institute, University Hospital Frankfurt. DNA concentration was measured using the Qubit DNA BR Assay Kit and Qubit 3 Fluorometer device (Invitrogen, Life Technologies Corporation, Oregon, USA). DNA was processed and hybridized to the Human Methylation EPIC v1 array beadchip (Illumina, San Diego, California, USA) following protocols provided by the manufacturer. The EPIC array beadchips were scanned with an iScan device (Illumina, San Diego, California, USA) and raw intensity data (idats) was generated using the GenomeStudio software (Illumina, San Diego, California, USA). The idats were uploaded onto the website molecularpathology.org provided by the University of Heidelberg, Germany. The idats were furthermore analyzed using the R package “RnBeads” [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], which implements quality control steps including the removal of low-quality CpG probes (including cross-reactive [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]), as well as CpGs in annotated SNPs and on the sex chromosomes. Normalization of methylation data was carried out using the “dasen” method from the R package “watermelon” [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. The LUMP (“leukocyte unmethylation for purity”) algorithm was used to estimate the overall leukocyte contents from bulk tumor methylomes and uses 44 CpG sites particularly hypomethylated in leukocytes [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">DNA methylation-based tumor deconvolution</h3>
<p id="Par8">Reference-free tumor deconvolution of DNA methylation data was performed using “MeDeCom” [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>] and the 5000 most variably methylated CpGs. MeDeCom defines major patterns of data variation, called LMCs. One to ten LMCs (parameter: K) were computed and optimal parameter values for K and the regularization parameter lambda (values tested: 0, 0.01, 0.001, 0.0001) were determined using the cross-validation error. Reference-based deconvolution of tumor methylomes was performed with the R package “MethylCIBERSORT” [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. A reference matrix was built based on two matrices, one from the neoplastic cell fractions from [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>] and the second from the non-neoplastic, immune-cell fractions of a reference matrix kindly provided by Tim R Fenton [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. The reference matrix allows for deriving the cellular composition of a glioma sample through cell type-specific methylation patterns of selected CpG sites according to [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Briefly, idats were imported into the R package “minfi” for quality checks, Noob normalization, and acquisition of beta values. The beta value matrices were uploaded onto the CIBERSORT website, and cell type proportions were computed (provided by the Alizadeh Lab, Stanford University, USA, developed by [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Computation of epigenetic tumor ages and DNA methylation age acceleration</h3>
<p id="Par9">For computation of the tumors’ epigenetic ages we used the “RnBeads” R package [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. DNA methylation age acceleration was calculated by subtracting chronological from epigenetic age.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Correlation of DNA methylation with CpG island (CGI) relation and chromatin landscape</h3>
<p id="Par10">We determined hyper- vs. hypomethylated sites for each of the LMCs by comparing the DNA methylation states in the LMCs versus the mean of the remaining LMCs using a cutoff of 0.25 as the minimum methylation difference. CpGs are determined as LMC-specifically hypomethylated if their methylation state is less than 0.25 compared to the mean of the other LMCs, and hypermethylated, respectively. For each of the CpGs, we retrieved its University of California Santa Cruz (UCSC) Genome Browser-based gene annotation and CGI relation. The genomic coordinates of each CpG site were mapped to their location within the chromatin landscape by comparison with universal chromatin state annotations of the human genome using a ChromHMM model as described in [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Subgroups within each major group of genomic annotations were summarized, like “ReprPC” for original ReprPC subgroups 1–9, for instance.</p>
<section id="Sec9"><h4 class="pmc_sec_title">TCGA validation cohort</h4>
<p id="Par11">DNA methylation and meta data from the TCGA low grade glioma (LGG) cohort was downloaded (<em>n</em> = 529 cases). Heidelberg Epignostix brain tumor classifier results were collected for the whole TCGA LGG cohort, and re-classification was performed according to the current version of the WHO classification of CNS tumors. Patient reports were reviewed for clinical follow up on patient overall survival for computation of the overall survival probability based on the Kaplan–Meier method. 406 tumors were classifiable as IDH mutant gliomas; 123 tumors were excluded because they were either not classifiable or did not belong to the methylation class of IDH mutant gliomas. 165 tumors showed a 1p/19q-codeletion. Histology reports were reviewed for microvascular proliferation or necrosis, and a CNS WHO grade 3 was assigned if either one was described. CNS WHO grade 3 was assigned if no further information about malignancy signs was available, while the sample was annotated as “anaplastic” in the TCGA documentation. Samples without described necrosis and microvascular proliferation or the annotation “anaplastic” were allocated to CNS WHO grade 2. Additionally, for the 165 gliomas with 1p/19q-codeletion, information about additional copy number alterations (present/absent) and <em>CDKN2A/B</em> deletion status (no alteration/heterozygous deletion/homozygous deletion) were collected based on visual inspection of copy number profiles as described for the training cohort. For the 241 IDH mutant gliomas with intact 1p/19q, the methylome-based copy number profiles were reviewed for homozygous deletion of <em>CDKN2A/B</em>. If the latter, or necrosis or microvascular proliferation was present, we assigned a CNS grade 4. Astrocytomas without necrosis or microvascular proliferation but the annotation “anaplastic” in the TCGA documentation were assigned to a grade 3; else (i.e. without the annotation “anaplastic”) to a grade 2. TCGA oligodendroglioma patients with a documented event of death were identified by the column “vital status” and were chosen for a sub cohort analysis. The patterns of DNA methylation computed on the Frankfurt training cohort were transferred to the TCGA cases using MeDeCom’s “factorize.regr” function. Based on the information of LMC composition from the training cohort, LMC proportions were analogously computed for the TCGA validation cohort. The 1p/19q-codeleted tumors were dichotomized according to CNS WHO grade and LMC1 proportions less or higher than 0.39.</p></section><section id="Sec10"><h4 class="pmc_sec_title">Statistical analysis</h4>
<p id="Par12">Overall survival (OS) was calculated according to the Kaplan–Meier method. Log-Rank p values were computed. All statistical analyses were carried out using JMP18 (SAS, Cary, North Carolina, USA) or R (R Core Team, 2019). The correlation plots were computed with the R package “corrplot” using Pearson correlation coefficients. For figure design, Affinity Designer software was used (version 1.10.6.1665, Serif (Europe) Ltd, Nottingham, UK). The Pearson Chi<sup>2</sup> test and Likelihood Ratio test were used for categorical variables in contingency tables. For non-parametric data, Wilcoxon, Kruskal–Wallis’ and Dunn’s tests were used. A recursive partitioning model was used with LMC1 proportions as a predictor of the dependent variable (presence or absence of copy number variations (CNVs) in addition to 1p/19q-codeletion in oligodendrogliomas) in the training cohort (<em>n</em> = 58, exclusion of <em>n</em> = 2 samples due to non-eligible copy number profiles). A p-value below 0.05 was considered statistically significant.</p></section></section></section><section id="Sec11"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Study cohort and workflow</h3>
<p id="Par13">The study cohort comprised 137 patients with IDH mutant gliomas treated in the tertiary center for neuro-oncology at Goethe University Hospital in Frankfurt, Germany. Patient sex (p 0.8601, Fisher’s exact test), Karnofsky Performance Score (KPS; p 0.2650, Wilcoxon), extent of resection (p 0.6901, Pearson) and treatment strategies (p 0.3617, Pearson) were equally distributed among 77 astrocytomas (WHO CNS grade 2–12 (16%), grade 3–39 (51%), grade 4–26 (34%)) and 60 oligodendrogliomas (WHO CNS grade 2–21 (35%), grade 3–39 (65%)) (Table <a href="#Tab1" class="usa-link">1</a>). Age at diagnosis was significantly higher in oligodendroglioma compared to astrocytoma patients (median: 35 vs. 43 years, p 0.0006, Wilcoxon). Calibrated scores from the Heidelberg brain tumor classifier for the methylation subclass of IDH mutant glioma reached 0.99 in median for both glioma subtypes [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. 22% of astrocytomas and 7% of oligodendrogliomas, respectively, had an unmethylated MGMT promoter (<em>p</em> 0.0156, Fisher’s exact test). Furthermore, recurrent tumors were more frequent among oligodendrogliomas (<em>p</em> 0.0430, Fisher’s exact test). For 3% of oligodendrogliomas, information about brain tumor classifier results was inconclusive, but tumors showed a clear 1p/19q-codeletion in methylome-based copy number profiling and were therefore classified as oligodendrogliomas.
</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Description of the main study cohort</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Astrocytoma (<em>n</em> = 77)</th>
<th align="left" colspan="1" rowspan="1">Oligodendroglioma (<em>n</em> = 60)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Epidemiological and clinical parameters</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender n (%)</td>
<td align="left" colspan="1" rowspan="1">Male 48 (62), Female 29 (38)</td>
<td align="left" colspan="1" rowspan="1">Male 36 (60), Female 24 (40)</td>
<td align="left" colspan="1" rowspan="1">0.8601<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age at diagnosis median (range) in years</td>
<td align="left" colspan="1" rowspan="1">35 (18–62)</td>
<td align="left" colspan="1" rowspan="1">43 (16–70)</td>
<td align="left" colspan="1" rowspan="1">0.0006<sup>b</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Primary tumor n (%)</td>
<td align="left" colspan="1" rowspan="1">63 (83)</td>
<td align="left" colspan="1" rowspan="1">40 (67)</td>
<td align="left" colspan="1" rowspan="1">0.0430<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KPS prior to surgery median (range)</td>
<td align="left" colspan="1" rowspan="1">100 (70–100)</td>
<td align="left" colspan="1" rowspan="1">100 (20–100)</td>
<td align="left" colspan="1" rowspan="1">0.2650<sup>b</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Extent of resection n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.6901<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Total</td>
<td align="left" colspan="1" rowspan="1">16 (27)</td>
<td align="left" colspan="1" rowspan="1">11 (25)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt; 90%</td>
<td align="left" colspan="1" rowspan="1">12 (20)</td>
<td align="left" colspan="1" rowspan="1">6 (14)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt; 90%</td>
<td align="left" colspan="1" rowspan="1">9 (15)</td>
<td align="left" colspan="1" rowspan="1">10 (23)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Biopsy only</td>
<td align="left" colspan="1" rowspan="1">22 (37)</td>
<td align="left" colspan="1" rowspan="1">17 (39)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.3617<sup>c</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Radiation + Chemotherapy</td>
<td align="left" colspan="1" rowspan="1">53 (69)</td>
<td align="left" colspan="1" rowspan="1">36 (62)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Resection only</td>
<td align="left" colspan="1" rowspan="1">13 (17)</td>
<td align="left" colspan="1" rowspan="1">7 (12)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Radiation only</td>
<td align="left" colspan="1" rowspan="1">4 (5)</td>
<td align="left" colspan="1" rowspan="1">7 (12)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chemotherapy only</td>
<td align="left" colspan="1" rowspan="1">2 (3)</td>
<td align="left" colspan="1" rowspan="1">4 (7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing data or no treatment</td>
<td align="left" colspan="1" rowspan="1">5 (6)</td>
<td align="left" colspan="1" rowspan="1">4 (7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Observation prior to resection n (%)</td>
<td align="left" colspan="1" rowspan="1">
<p>na/0 days 59 (77),</p>
<p>18 (23) median 2257 days (2–8115 days)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>na/0 days 41 (68),</p>
<p>19 (32) median 1787 days (21–5619 days)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Molecular parameters</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> V11b4 HD brain tumor classifier methylation class n (%)</td>
<td align="left" colspan="1" rowspan="1">Glioma, IDH mutant 77 (100)</td>
<td align="left" colspan="1" rowspan="1">Glioma, IDH mutant 58 (97), missing 2 (3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> V11b4 HD brain tumor classifier calibrated score median (range)</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.38–0.99)</td>
<td align="left" colspan="1" rowspan="1">0.99 (0.42–0.99)</td>
<td align="left" colspan="1" rowspan="1">0.6788<sup>b</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> V11b4 HD brain tumor classifier methylation subclass n (%)</td>
<td align="left" colspan="1" rowspan="1">Astrocytoma 62 (81), high-grade astrocytoma 15 (19)</td>
<td align="left" colspan="1" rowspan="1">Oligodendroglioma 1p/19q-codeleted 56 (93), astrocytoma 2 (3), missing 2 (3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> MGMT promoter methylation status n (%)</td>
<td align="left" colspan="1" rowspan="1">Unmethylated 17 (22), Methylated 57 (74), missing 3 (4)</td>
<td align="left" colspan="1" rowspan="1">Unmethylated 4 (7), Methylated 54 (90), missing 2 (3)</td>
<td align="left" colspan="1" rowspan="1">0.0156<sup>a</sup>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Histological parameters</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> WHO CNS grade 2</td>
<td align="left" colspan="1" rowspan="1">12 (16)</td>
<td align="left" colspan="1" rowspan="1">21 (35)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> WHO CNS grade 3</td>
<td align="left" colspan="1" rowspan="1">39 (51)</td>
<td align="left" colspan="1" rowspan="1">39 (65)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> WHO CNS grade 4</td>
<td align="left" colspan="1" rowspan="1">26 (34)</td>
<td align="left" colspan="1" rowspan="1">na</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p21">
<p>Epidemiological, clinical and molecular characteristics</p>
<p><em>P</em> values with numbers in superscript indicating statistical test: <sup>a</sup>Fisher’s exact test, <sup>b</sup>Wilcoxon, <sup>c</sup>Pearson; within “Extent of resection” and “Treatment”, respectively, all categories were considered together for <em>p</em> value computation</p>
<p><em>P</em> values highlighted in italic indicate significance</p>
</div></div></section><p id="Par14">DNA methylation profiling and reference-free deconvolution of 137 gliomas were performed following the protocols described in [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Briefly, MeDeCom extracts Latent Methylation Components (LMCs) and LMC proportions across the samples from the input bulk DNA methylation data using non-negative matrix factorization. We identified six LMCs representing major patterns of data variation based on the 5,000 most variably methylated CpGs (lambda 0.001; Supplementary Fig. <a href="#MOESM2" class="usa-link">1</a>a; Material and Methods). Patients with astrocytoma, CNS WHO grade 4, showed the worst overall survival within the study cohort (Supplementary Fig. <a href="#MOESM2" class="usa-link">1</a>b).</p></section><section id="Sec13"><h3 class="pmc_sec_title">LMC-based classification partially overlaps with epigenetically classified glioma subtypes and CNS malignancy grades</h3>
<p id="Par15">LMC proportions within the study cohort showed glioma subtype-specific patterns. While LMCs 3 and 6 were associated with astrocytomas, oligodendrogliomas showed higher proportions of LMC1, 2, and 5 (Fig. <a href="#Fig1" class="usa-link">1</a>a). Among epigenetic subclasses of astrocytoma defined by the Heidelberg classifier, high-grade astrocytomas showed significantly higher scores for LMC3 and lower scores for LMC6 compared to the methylation subclass “astrocytoma” (<em>p</em> &lt; 0.0001, Likelihood and Pearson; Fig. <a href="#Fig1" class="usa-link">1</a>b). Proportions of oligodendroglioma-specific LMC1 were significantly higher in CNS WHO grade 3 than 2 (<em>p</em> 0.0058; Fig. <a href="#Fig1" class="usa-link">1</a>c, d). Conversely, CNS grade 2 oligodendrogliomas showed higher scores for LMC5 (<em>p</em> 0.0011). For astrocytomas of CNS WHO grades 2 and 3, we observed highest LMC6 scores (2 vs. 4 <em>p</em> 0.0013; 3 vs. 4 <em>p</em> 0.0024), whereas CNS WHO grade 4 astrocytomas were characterized by highest LMC3 scores (4 vs. 2 <em>p</em> 0.0003; 4 vs. 3 <em>p</em> &lt; 0.0001).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374884_401_2025_2926_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e6/12374884/37a72b24a476/401_2025_2926_Fig1_HTML.jpg" loading="lazy" id="MO1" height="1062" width="792" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Associations of LMC proportions with glioma subtypes and grades of the training cohort. <strong>a</strong> LMC 1–6 proportions in IDH mutant astrocytomas vs. oligodendrogliomas, box plots. <strong>b</strong> Distribution of frequency of LMC predominancy 1/3/5/6 within tumors assigned to methylation classes “1p/19q-codeleted oligodendroglioma”, “astrocytoma” or “high-grade astrocytoma”, contingency table. <strong>c</strong> Distribution of LMC proportions in gliomas according to subtype “oligodendroglioma” or “astrocytoma” with respect to CNS WHO grades. Box plots with indicated median LMC values. <strong>d</strong> Distribution of LMC proportions 3 and 6 (upper panel) for astrocytoma CNS WHO grades and 1 and 5 (lower panel) for oligodendroglioma CNS WHO grades, box plots. <strong>e</strong> Distribution of frequencies of LMC 1/3/5/6 predominancy within tumors, stratified according to subtypes and CNS WHO grades. <strong>f</strong> Distribution of frequencies of LMC 1/5 predominancy within oligodendrogliomas of all CNS WHO grades. <strong>g</strong> Distribution of frequencies of LMC 3/5/6 predominancy within astrocytomas of all CNS WHO grades. <strong>h</strong> Genome-wide methylation in tumors stratified according to LMC predominancy. <em>P</em> values * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001</p></figcaption></figure><p id="Par16">Subsequently, we attributed each glioma to its dominant LMC by assigning it to the LMC with the highest proportion. LMC1-predominant tumors were exclusively oligodendrogliomas, with 78.1% corresponding to CNS WHO grade 3 and 21.9% to grade 2 (Fig. <a href="#Fig1" class="usa-link">1</a>e). LMC3-predominancy was exclusive to higher-grade astrocytoma (84.2% CNS WHO grade 4 and 15.8% of grade 3). LMC6-predominant tumors were astrocytomas, with 60.8% of CNS WHO grade 3, and 19.6% of grade 2 and 4, respectively. The LMC5 predominant group was mixed: 40% of CNS WHO grade 2 oligodendrogliomas, 40% of grade 3 oligodendrogliomas, as well as 14.3% of grade 3 and 5.7% of grade 2 astrocytoma. For oligodendrogliomas, dominant LMC patterns were limited to LMC1 and LMC5; higher CNS WHO grade was significantly associated with LMC1-predominancy (<em>p</em> 0.0219 Likelihood, <em>p</em> 0.0227 Pearson; Fig. <a href="#Fig1" class="usa-link">1</a>f). For astrocytomas, we observed that LMC-predominancy depended on CNS WHO grade: The higher the CNS WHO grade in astrocytoma, the more likely tumors clustered within the LMC3-predominant group with lower proportions of LMC5 and 6 (<em>p</em> &lt; 0.0001; Fig. <a href="#Fig1" class="usa-link">1</a>g). LMC3-dominant tumors furthermore showed a significant reduction in genome-wide methylation levels as compared to all other LMC-dominant tumor groups (Fig. <a href="#Fig1" class="usa-link">1</a>h).</p></section><section id="Sec14"><h3 class="pmc_sec_title">LMC-based grading of glioma is associated with overall survival in a TCGA subgroup of oligodendroglioma patients</h3>
<p id="Par17">We determined a cutoff of 0.39 for the LMC1 proportion predicting the assignment to oligodendrogliomas with copy number alterations in addition to 1p/19q-codeletion in our discovery cohort using recursive partitioning (Supplementary Fig. <a href="#MOESM2" class="usa-link">1</a>c).</p>
<p id="Par18">To validate the computed patterns of high- vs. low-grade glioma associated LMCs, we transferred them into the TCGA LGG validation cohort comprising 406 tumors with 165 oligodendrogliomas (CNS WHO grade 2 <em>n</em> = 88, grade 3 <em>n</em> = 77) and 241 astrocytomas (CNS WHO grade 2 <em>n</em> = 115, grade 3 <em>n</em> = 74, grade 4 <em>n</em> = 52; Material and Methods). The relationship between LMCs and glioma subtypes and grades was largely preserved (Fig. <a href="#Fig2" class="usa-link">2</a>a). High proportions of LMC1 were associated with oligodendroglioma, CNS WHO grade 3, of LMC5 with oligodendroglioma, CNS WHO grade 2, of LMC3 with astrocytoma, CNS WHO grade 4, and of LMC6 with astrocytoma, CNS WHO grade 2/3 (Supplementary Fig. <a href="#MOESM2" class="usa-link">1</a>d).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374884_401_2025_2926_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e6/12374884/8c6695104020/401_2025_2926_Fig2_HTML.jpg" loading="lazy" id="MO2" height="1062" width="749" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Validation of LMCs and LMC-based grading. <strong>a</strong> Distribution of LMC proportions in TCGA LGGs stratified according to glioma subtype and CNS WHO grade. Box plots with indicated median LMC values. <em>P</em> values * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001. <strong>b</strong> Distribution of frequencies of oligodendrogliomas from the TCGA cohort within categories LMC &lt; and &gt; 0.39, respectively. <strong>c</strong> Kaplan–Meier survival curve for OS in TCGA oligodendrogliomas with event of death (n = 19) dichotomized according to &lt; / &gt; LMC1 = 0.39 (LMC1 &lt; 0.39, <em>n</em> = 12; LMC1 &gt; 0.39, <em>n</em> = 7). <strong>d</strong> Kaplan–Meier survival curve for OS in TCGA oligodendrogliomas with fatal disease course dichotomized according to LMC1 cutoff-based grading in relation to CNS WHO grades (LMC/WHO match grade 2, <em>n</em> = 4; Down from grade 3, <em>n</em> = 8; Up from grade 2, <em>n</em> = 1; LMC/WHO match grade 3, <em>n</em> = 6). <strong>e</strong> Contingency table for frequencies of <em>CDKN2A/B</em> copy number alterations “none”, “hom” (homozygous deletion) and “het” (heterozygous deletion) in oligodendrogliomas of the TCGA training cohort stratified according to LMC1 proportion &lt; / &gt; 0.39. <strong>f</strong> Contingency table for frequencies of copy number variations (CNV) in addition to 1p/19q-codeletion in oligodendrogliomas graded by LMC proportions into matching, down- or upgraded samples in comparison to CNS WHO grades. <strong>g</strong> Contingency table for frequencies of <em>CDKN2A/B</em> copy number alterations “none”, “hom” (homozygous deletion) and “het” (heterozygous deletion) in oligodendrogliomas graded by LMC proportions into matching, down- or upgraded samples in comparison to CNS WHO grades</p></figcaption></figure><p id="Par19">Samples with proportions of LMC1 larger than 0.39 in the TCGA validation cohort were more likely higher- than lower-grade oligodendrogliomas (Fig. <a href="#Fig2" class="usa-link">2</a>b). Among patients of the TCGA cohort with a fatal disease course (<em>n</em> = 19 of 165) oligodendrogliomas with LMC1 proportions bigger than 0.39 were associated with shorter overall survival (Fig. <a href="#Fig2" class="usa-link">2</a>c). Along that line, using LMC-based grading, patients whose tumors were downgraded from a WHO grade 3 showed a more beneficial overall survival than those with a match for grade 3 between WHO- and LMC-based grading as well as those upgraded from a WHO grade 2 (Fig. <a href="#Fig2" class="usa-link">2</a>d). While the LMC-based grading helped to identify patients with the worst overall survival among those with least beneficial disease courses, it did not capture differences in overall survival for the whole TCGA cohort oligodendrogliomas after stratification according to LMC1 proportions or LMC-based match/up- or downgrade in relation to WHO grades as compared to WHO-based grading (Supplementary Fig. <a href="#MOESM2" class="usa-link">1</a>e). Oligodendrogliomas with homozygous deletion of <em>CDK2NA/B</em> were significantly enriched within tumors harboring LMC1 proportions higher than 0.39 (Fig. <a href="#Fig2" class="usa-link">2</a>e). Samples displaying higher-grade traits based on WHO- or LMC-grading (“LMC/WHO match grade 3” and “up from grade 2”) were more likely to present with additional copy number alterations beyond 1p/19q-codeletion. Oligodendrogliomas with LMC-based grading indicative of a lower-grade glioma (“down from grade 3”) on the contrary, were less likely to show additional copy number aberrations, like “LMC/WHO match grade 2” (Fig. <a href="#Fig2" class="usa-link">2</a>f). Along that line, samples displaying homozygous <em>CDKN2A/B</em> deletion majorly enriched within the groups “LMC/WHO match grade 3” and LMC-based “up from grade 2” (Fig. <a href="#Fig2" class="usa-link">2</a>g).</p></section><section id="Sec15"><h3 class="pmc_sec_title">Distinct LMCs correlate with general H&amp;E histopathological, aging and contrast agent- enrichment traits of tumors</h3>
<p id="Par20">LMC3 correlated significantly with increased mitotic and proliferative activity, the latter measured by Ki67 immunoreactive nuclei, whereas LMC5 and 6 showed a significant negative correlation with mitotic frequency and proliferation (Fig. <a href="#Fig3" class="usa-link">3</a>a). LMC1, 2, and 4 were not significantly associated with mitotic frequency or proliferative activity.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374884_401_2025_2926_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e6/12374884/0f3537e1c4f7/401_2025_2926_Fig3_HTML.jpg" loading="lazy" id="MO3" height="1061" width="701" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Association of LMCs with markers of tumor proliferation, histological signs of malignancy and age metrics. <strong>a</strong> Correlation of LMC 1–6 proportions with proliferative activity, measured by estimation of Ki67 immunoreactive nuclei and mitotic frequency/mm<sup>2</sup>. Pearson correlation (Pearson corr.) coefficients are color-coded from 1 (yellow, strong positive correlation; ascending ellipse) to −1 (purple, strong negative correlation; descending ellipse). “X” indicates non-significant correlations. <strong>b</strong> Comparison of LMC 1–6 proportions with cellular density (“intermediate”, “low”, “high”), necrosis (present “1”, absent “0”) and microvascular proliferation (present “1”, absent “0”). <em>P</em> values * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001. <strong>c</strong> Correlation of LMC1-6 proportions with patients’ chronological ages, epigenetic ages and DNA methylation age acceleration. Pearson correlation (Pearson corr.) coefficients are color-coded from 1 (yellow, strong positive correlation; ascending ellipse) to −1 (purple, strong negative correlation; descending ellipse) and elliptical shape indicate stronger correlation. “X” indicates non-significant correlations</p></figcaption></figure><p id="Par21">LMC3 was significantly associated with the presence of necrosis and microvascular proliferation as histopathological signs of malignancy in tumors (<em>p</em> &lt; 0.0001; Fig. <a href="#Fig3" class="usa-link">3</a>b). High proportions of LMC1 were associated with elevated tumor cell density and absence of necrosis (<em>p</em> 0.0038 and 0.0167, respectively). Tumors with high LMC6 proportions were less likely to present with high cellularity, microvascular proliferation, or necrosis (<em>p</em> 0.0022, 0.0002, 0.0006 and 0.0011, respectively). LMC2, LMC4, and LMC5 were not significantly associated with any histological markers of malignancy. LMC3-predominant tumors showed enrichment of contrast agent in MRI scans as a marker of higher-grade glioma in up to 80% of cases. In contrast, LMC5-predominant tumors presented without contrast agent enrichment in 76.7% (Supplementary Fig. <a href="#MOESM2" class="usa-link">2</a>a). The assignment of predominant LMCs to gliomas was independent of patient sex (Supplementary Fig. <a href="#MOESM2" class="usa-link">2</a>b).</p>
<p id="Par22">Next, we checked for association of LMC proportions with aging parameters as age is an important risk factor for higher grade gliomas and the subtypes of IDH mutant glioma were shown to differ in terms of DNA methylation age acceleration [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. DNA methylation age acceleration is computed by subtraction of the patients’ chronological ages from epigenetic ages derived from the tumor methylomes using a methylclock [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. While LMC1 proportions in tumors correlated positively with chronological patient ages, there was a negative correlation between LMC5 and 6 and age (LMC1 R<sup>2</sup> corr. 0.2, <em>p</em> &lt; 0.0001; LMC5 R<sup>2</sup> corr. 0.017, <em>p</em> 0.071; LMC6 R<sup>2</sup> corr. 0.084, <em>p</em> 0.0003; Fig. <a href="#Fig3" class="usa-link">3</a>c). Similarly, we observed an association between LMC1 and epigenetic aging (R<sup>2</sup> corr. 0.39, <em>p</em> &lt; 0.0001). Higher LMC6 scores on the contrary correlated negatively with epigenetic age (R<sup>2</sup> corr. 0.23, <em>p</em> &lt; 0.0001). Along that line, tumors with high LMC1 proportions were characterized by increased DNA methylation age acceleration while high LMC6 proportions in glioma correlated with DNA methylation age deceleration (LMC1 R<sup>2</sup> corr. 0.18, <em>p</em> &lt; 0.0001; LMC6 R<sup>2</sup> corr. 0.14, <em>p</em> &lt; 0.0001). The other LMCs were not significantly associated with chronologic or epigenetic age metrics. In general, oligodendrogliomas of higher malignancy grade showed higher epigenetic age compared to astrocytomas, whilst chronological patient age exclusively differed between oligodendroglioma and astrocytoma of grade 3 (Supplementary Fig. <a href="#MOESM2" class="usa-link">2</a>c). DNA methylation age acceleration however was significantly increased in oligodendroglioma grade 3 in comparison to astrocytomas of all WHO CNS grades. LMC1-dominant tumors showed highest chronological and epigenetic ages. Chronological and epigenetic age were significantly associated with LMCs 5 and 6, and epigenetic age was significantly higher in LMC1- than LMC3-dominant tumors (Supplementary Fig. <a href="#MOESM2" class="usa-link">2</a>d). LMCs 1 and 5 showed significantly higher DNA methylation age acceleration in comparison to LMC3 and 6. Most oligodendrogliomas in our training cohort were initially diagnosed after neurosurgical resection, but for some tumor growth was observed for a longer time period (median 1787 days). Within the latter subgroup of oligodendroglioma, the increase of epigenetic age depended on CNS WHO grade majorly but not on the period of observed tumor growth (Supplementary Fig. <a href="#MOESM2" class="usa-link">2</a>e).</p></section><section id="Sec16"><h3 class="pmc_sec_title">LMC1 and LMC3 correlate positively with tumor cell content</h3>
<p id="Par23">LMCs were subjected to DNA methylation-based, reference-based tumor deconvolution to infer their cellular composition [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. LMC1 and LMC3, which were rather associated with higher-grade tumors, showed significant positive correlation with cancer cell proportions (LMC1 R<sup>2</sup> corr. 0.070, <em>p</em> 0.011; LMC3 R<sup>2</sup>corr. 0.26, <em>p</em> &lt; 0.0001; Fig. <a href="#Fig4" class="usa-link">4</a>a) whereas correlations with immune cell subsets and monocytes were negative. Higher scores for LMC5 and LMC6, on the other hand, correlated negatively with cancer cell proportions (LMC5 R<sup>2</sup> corr. 0.22, <em>p</em> &lt; 0.0001; LMC6 R<sup>2</sup> corr. 0.13, <em>p</em> &lt; 0.0001) but positively with B and T cell subsets. Notably, LMC6 proportions positively correlated with predicted monocyte content (R<sup>2</sup> corr. 0.45, <em>p</em> &lt; 0.0001). Along this line, we employed the LUMP algorithm to infer overall leukocyte proportions in LMCs. LMC1 correlated negatively with LUMP proportions, while higher LMC6 proportions coalesced with higher LUMP scores (LMC1 R<sup>2</sup> corr. 0.23, <em>p</em> &lt; 0.0001; LMC6 R<sup>2</sup> corr. 0.16, <em>p</em> &lt; 0.0001). The estimated cancer cell proportions for LMC1- and LMC3-dominant tumors did not differ between each other but were significantly higher than those computed for the lower-grade glioma-associated LMCs 5 and 6 (Fig. <a href="#Fig4" class="usa-link">4</a>b).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374884_401_2025_2926_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e6/12374884/f121b41d82fa/401_2025_2926_Fig4_HTML.jpg" loading="lazy" id="MO4" height="445" width="676" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Association of LMC proportions with cellular composition of gliomas. <strong>a</strong> Correlation of LMCs 1, 3, 5, and 6 with estimates of immune cells (B cells, CD4 effector T cells, NK cells and T regulatory cells), monocytes, cancer cells, and LUMP. Pearson correlation (Pearson corr.) coefficients are color-coded from 1 (yellow, strong positive correlation; ascending ellipse) to −1 (purple, strong negative correlation; descending ellipse) and elliptical shape indicates stronger correlation. “X” indicates non-significant correlations. <strong>b</strong> Distribution of cancer cell estimates in tumors stratified according to LMC predominancy, box plots. <em>P</em> values * &lt; 0.05, ** &lt; 0.01, *** &lt; 0.001</p></figcaption></figure></section><section id="Sec17"><h3 class="pmc_sec_title">High-grade LMCs 1 and 3 show G-CIMP characteristics</h3>
<p id="Par24">We next set out to analyze the differential epigenetic backbone of LMC composition in high- vs. low-grade associated LMCs. To that end, we performed differential analysis between each LMC compared to all other LMCs and defined LMC-specific hypo- and hypermethylated CpGs (Material and Methods). Sites hypermethylated in LMCs 5 and 6 were mainly located outside of CpG islands (termed ‘open sea’; Fig. <a href="#Fig5" class="usa-link">5</a>a). Conversely, CpGs hypomethylated in LMC5 and 6 were preferentially located within and in proximity to CpG islands. This pattern was reversed in high-grade glioma-associated LMCs 1 and 3 as they harbored hypomethylation mainly in open sea regions and hypermethylation in chromatin regions mapping within the north shore, CpG island, and south shore.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374884_401_2025_2926_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e6/12374884/37355d4224b8/401_2025_2926_Fig5_HTML.jpg" loading="lazy" id="MO5" height="653" width="676" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Epigenetic backbone of LMCs. <strong>a</strong> Distribution of frequencies of hyper- or hypomethylation with respect to CGI relation in low-grade vs. high-grade LMCs. <strong>b</strong> Distribution of hyper- and hypomethylation frequencies with respect to summarized chromatin landscape universal annotation in high-grade vs. low-grade LMCs. <strong>c</strong> Location of hyper- and hypomethylated CpGs with respect to different chromatin states comparing high-grade LMCs associated with oligodendroglioma (LMC1) vs. astrocytoma (LMC3). Values are displayed in % of hyper- or hypomethylation separately within each LMC category. Human genome regions associated with the following states/traits according to Universal Annotation [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]: <em>Acet</em> Acetylated chromatin, <em>BivProm</em> Bivalent Promoters, <em>DNase</em> DNase I hypersensitivity, <em>Enh</em> Enhancers, <em>GapArtf</em> Assembly gaps and alignment artifacts, <em>HET</em> Heterochromatin, <em>Quies</em> Quiescent chromatin, <em>PromF</em> Promoter flanking, <em>ReprPC</em> Polycomb repressed chromatin, <em>TSS</em> Transcriptional start sites, <em>Tx</em> Exons and transcription, <em>znf</em> Zinc finger</p></figcaption></figure><p id="Par25">In higher-grade LMCs 1 and 3, 28.8%, 19.7%, and 18.3% of hypermethylated CpGs were located in bivalent promoters (BivProm), sites repressed by polycomb (ReprPC) and promoter-flanking chromatin regions (PromF), whereas hypermethylated CpGs in lower-grade LMCs 5 and 6 mapped with enhancers (Enh; 34.7%), hetero- and quiescent chromatin (HET + Quies; 25.1%), polycomb-repressed sites (ReprPC; 3%) and acetylated chromatin regions (Acet; 10.3%; Fig. <a href="#Fig5" class="usa-link">5</a>b).</p>
<p id="Par26">Hypomethylation at enhancers and hypermethylation at bivalent promoters was one of the major patterns found in both high-grade LMCs (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>a, b). When compared to LMC1, LMC5 composition was characterized by more hypermethylated CpGs mapping with hetero- and quiescent chromatin and enhancers as well as hypomethylated sites located within bivalent promoters and promoter flanking CpGs (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>c). These results were similar for the comparison between the composition of astrocytoma-associated LMC 6 vs. 3 (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>d). Overall, LMC1 was defined by significantly more hypermethylated sites than LMC5 (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>e). The number of hypo- and hypermethylated sites forming LMC3 and 6 was balanced (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>f). Between the glioma subtype-specific LMCs, there was majorly no overlap of CpGs (Supplementary Fig. <a href="#MOESM2" class="usa-link">3</a>g, h).</p></section></section><section id="Sec18"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par27">Epigenetic profiling became an indispensable component for a comprehensive evaluation of brain tumors in neuropathological diagnostics. Classification tools, like the Heidelberg brain tumor classifier, are based on the robustness of tumor-type-specific DNA methylation patterns. Deconvolution analysis, on the other hand, allows for an unsupervised analysis of DNA methylation data, facilitating the discovery of novel tumor-associated methylation patterns irrespective of additional confounding factors [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>].</p>
<p id="Par28">In 137 IDH-mutant gliomas, we showed differences between IDH mutant glioma subtypes on methylation level similar to LGm1-3 groups defined by Cecarrelli et al. [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. LMCs were exclusively associated with either astrocytoma or oligodendroglioma, 1p/19q-codeleted. LMC analysis, however, reflected histological parameters of high- vs. low-grade gliomas, which were not apparent upon separation of LGm1/LGm2 associated with 1p/19q-intact and LGm3 1p/19q-codeletion-enriched methylome-based clusters [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. LMC3 defined a high-grade astrocytoma LMC, with features such as increased mitotic frequencies, while LMC6 defined a low-grade astrocytoma DNA methylation subtype. Similarly, CNS WHO grade 2 oligodendrogliomas presented with higher proportions of LMC5, whereas CNS WHO grade 3 tumors harbored higher ratios for the oligodendroglioma-specific LMC1. Changes of LMC proportions in glioma might thus reflect their malignant transition from lower- to higher-grade astrocytoma and oligodendroglioma, respectively.</p>
<p id="Par29">We observed hypermethylation in high-grade LMCs compared to low-grade LMCs at and around CpG islands, at the expense of hypermethylation of sites located in open sea regions. Previous work has established a clear link between IDH mutant gliomas and the glioma CpG island hypermethylator (G-CIMP) phenotype [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. DNA hypermethylation of CpG islands was characterized as a stable phenomenon as it persists in recurrent G-CIMP gliomas independent of the CNS grade [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Nevertheless, a prognostically unfavorable genome-wide hypomethylation was shown in recurrent IDH mutant, non-codeleted gliomas [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. G-CIMP high to low progression overall was found to be a process independent from initial glioma grade leading to a phenotype resembling mesenchymal-like IDH wildtype glioblastoma [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Analysis conducted by Mur et al. argues for differences in G-CIMP-related methylation distribution across glioma subtypes because codeleted glioma-CIMP cases showed slightly increased proportions of hypermethylated CpG sites at islands at the expense of open sea regions when compared to non-codeleted glioma-CIMP samples [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. LMC1- vs. -5- and -6-dominant tumors show comparable overall-genome-wide methylation levels. Nevertheless, the high- and low-grade LMCs differ with regard to cancer cell proportions, which might be an indication that the lower-grade LMC signature is driven by non-neoplastic cellular components of the tumor microenvironment. The fact that the higher-grade LMCs are composed of either oligodendroglioma or astrocytoma but the lower-grade LMC5 is mixed would corroborate this hypothesis. In future experiments, single-cell methylome analysis will be needed to answer how much each single neoplastic and non-neoplastic cell type contributes to each of the LMCs. It is, however, up for discussion whether malignant transition emphasizes a distinct methylation phenotype which is pre-arranged but not yet dominant in lower-grade glioma tumor cells. Since glioma methylomes from bulk tumors are routinely acquired and subjected to classifier tools for diagnostic purposes, there is a clinical need for approaches for refined glioma grading which reflect the common tissue and data type; the inclusion of tumor microenvironmental traits for tumor classification thereby is mandatory.</p>
<p id="Par30">We observed an enrichment of hypermethylation at bivalent promoters in high-grade LMCs, which are associated with genes involved in cell differentiation and development in embryonic stem cells. Bivalent genes are often targeted by aberrant DNA methylation in human cancers while being hypomethylated in non-neoplastic cells, like embryonic stem cells [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. DNA methylation-induced irreversible gene silencing of bivalent genes is shown to be leveraged by a resolution of their histone modification hallmark pattern, the H3K4me3/H3K27me3-double marking, which might give rise to cellular adaptation and epigenetic plasticity thereby fueling malignant behavior in gliomas [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Tissue-specific bivalent gene expression in development is furthermore shown to be orchestrated via a synergistic effect between bivalent promoters and active enhancers marked by H3K27ac and therefore exhibiting an accessible chromatin conformation [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Potentially, hypomethylation of enhancers as observed in higher-grade LMCs might contribute to a chromatin configuration which facilitates gene expression. Since in higher-grade astrocytoma it is shown that although developmental genes gained DNA hypermethylation, their expression was increased instead of silenced, bivalent genes might potentially benefit from aberrant enhancer activation thereby bringing higher order chromatin structure into play as a mechanism facilitating malignant glioma transition [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par31">Oligodendrogliomas stood out by showing the highest epigenetic ages. Epigenetic aging and DNA methylation age acceleration recently emerged as potential biomarkers in diffuse glioma; however, underlying mechanisms and consequences are far from being well understood. Increased epigenetic aging has already been described for oligodendroglioma, IDH mutant and 1p/19q-codeleted, in comparison to IDH wildtype gliomas and IDH mutants without codeletion, especially when the Horvath pan-age and pan-tissue methylclocks were used for epigenetic age computation [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. By use of a mitosis-related methylclock for epigenetic age estimation, epiTOC, the authors found the classic subtype of glioblastoma to also be associated with increased aging on an epigenetic level. Along that line, and in IDH wildtype glioblastoma, we and others found positive effects of tumors with increased epigenetic aging on patient survival [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. This study, however, argues for a more careful interpretation of the biomarker epigenetic aging in IDH mutant glioma because WHO CNS grade 3 oligodendrogliomas, as well as LMC1-dominant tumors, showed higher age metrics than their WHO CNS grade 2 counterparts and LMC5-dominant tumors. Since higher chronological age is associated with higher CNS WHO grade in oligodendroglioma, it is challenging to discriminate between the effects imposed on epigenetic aging by higher-grade tumor biological processes vs. duration of in vivo tumor growth [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Arguing for methylation changes due to higher-grade tumor-specific intrinsic processes, however, is the fact that in our cohort, epigenetic ages did not differ with regard to in vivo growth duration (longer or shorter than the cohort median of 1787 days for oligodendrogliomas) but majorly to CNS WHO grades. This suggests that an increase in epigenetic ages is accompanied by a higher-grade phenotype in oligodendroglioma.</p>
<p id="Par32">We identified LMC1 as the methylome-based equivalent of high-grade oligodendroglioma. Unlike LMC3-dominant tumors, tumors scoring high for LMC1 did not show apparent histological signs of malignancy in that there was no association with microvascular proliferation or necrosis. Figarella-Branger et al., who studied roughly 500 patients suffering from oligodendroglioma, stratified the tumors according to brisk mitotic activity of &gt; / = 2.5 mitotic figures/mm<sup>2</sup> and presence of necrosis and/or microvascular proliferation. They observed a 91% 5-year OS in group 1 harboring&gt; / = 2.5 mitoses/mm², vs 85% in group 2 harboring microvascular proliferation, and 77% in group 3 harboring microvascular proliferation and necrosis [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. An advantage of our LMC-based grading approach is the independence from sampling of the most malignant tumor hotspot. Furthermore, LMC-based grading reflected changes of copy number, in that it stratified oligodendrogliomas according to present copy number variations in addition to 1p/19q-codeletion as well as homozygous deletion of <em>CDKN2A/B</em>. While current data support the understanding of a negative impact on overall survival when <em>CDKN2A/B</em> is homozygously deleted, this was not shown for heterozygous <em>CDKN2A/B</em> deletions [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. It is intriguing that LMC-based grading separated the oligodendrogliomas according to homo- but not heterozygous <em>CDKN2A/B</em> deletion status, except for a single grade 2 tumor not meeting any malignancy criterium besides the homozygous <em>CDKN2A/B</em> deletion. Future research is needed to explore the prognostic value and biomarker capacity of LMCs in oligodendroglioma in view of distinct tumor cell-specific epigenetic alterations promoting malignant behavior prior to apparent histological or radiological signs of higher-grade glioma.</p>
<p id="Par33">Also prone to sampling bias is mitotic frequency, which can furthermore be observer dependent. Giannini et al. tested the prevalence, correlation coefficients, and consensus rates of histological malignancy features in 124 lower-grade gliomas. They showed that even though mitotic activity belonged to traits with moderate or substantial interobserver reproducibility, it was not associated with cause-specific survival, which might have been caused by missing neuropathological expertise in one of two rater groups [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. In the hands of a trained neuropathologist, however, the mitotic count was assumed to mirror cause-specific survival differences, and the authors suggested a cutoff of 2.5 mitoses/mm<sup>2</sup>. Most comprehensive subsequent studies focused on the analysis of clinical and histological parameters in grade 3 oligodendroglioma only [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. The stratification into three groups (&gt; 2.5 mitoses/mm<sup>2</sup>, angiogenesis present, necrosis present with or without microvascular proliferation) by Figarella-Branger was accompanied by an increasing mitotic count but still did not reflect on OS in multivariate analysis [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. The lack of a firm definition of a mitotic count cutoff associated with malignancy in oligodendroglioma attenuates our finding of a missing correlation between mitotic count and LMC1 proportions, especially as malignancy features might co-occur in oligodendroglioma. Whether this implies a lower reliability of the biomarker mitotic count for grading needs further testing but warrants a more detailed CNS WHO grade discriminative analysis.</p>
<p id="Par34">In summary, we propose an epigenetically based support of IDH mutant glioma objectifying current grading strategies relying on morphological tumor traits mostly. For oligodendroglioma, LMC1 was associated with higher grade glioma morphology, CNS grade 3, alterations of the <em>CDKN2A/B</em> locus, and chromosomal aberrations in addition to 1p/19q-codeletion. Along that line, patients with tumors presenting with a LMC1 cutoff bigger than 0.39 showed the most unfavorable disease courses among those with registered events of death in comparison to those with cutoffs smaller than 0.39. On an epigenetic level, higher LMC1 proportions were related to hypermethylation at bivalent promoters and promoter-flanking CpG sites, as well as to hypomethylation at enhancers when compared to LMCs associated with lower grade gliomas, delineating potential mechanisms of malignant transition in gliomas. Although we were able to prove that LMC signatures are transferable between oligodendroglioma cohorts, further validation is required. This cutoff would have to stand up to tumor heterogeneity and ideally be able to indicate the very beginning or a critical methylation status switch in glioma evolution towards malignancy, thereby questioning especially this cutoff’s minimum. Future investigations of single-cell methylomes, as well as an increase in case numbers from multicenter cohorts, will target these requirements, ultimately leading to an improvement in oligodendroglioma grading. From a patho-mechanistical point of view, targeted and more expansive analyses of promoter-flanking CpGs, enhancers, and bivalent promoters are needed to elucidate their role in the malignant transition of oligodendroglioma. Since, analogous to LMC1, clear cutoffs for LMC3 are still missing, and our study focused on oligodendroglioma, the discrimination between grade 2 and 3 astrocytomas stays challenging as for now and awaits further in-depth investigation. Nevertheless, distinct methylation gains and losses shaping the understanding of epigenetic patterns of higher grade IDH mutant glioma were partially also encountered in lower-grade astrocytoma, potentially defining the initiation of a malignant transition by the acquirement of LMC3 proportions, which otherwise were mostly associated with grade 4 astrocytoma.</p></section><section id="Sec19"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12374884/bin/401_2025_2926_MOESM1_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (XLSX 66 KB)</a><sup> (65.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12374884/bin/401_2025_2926_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file2 (DOCX 1174 KB)</a><sup> (1.1MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank Maika Dunst and Tatjana Starzetz for excellent technical support. We thank Tim R. Fenton for kindly providing a reference matrix for reference-based tumor deconvolution. PSZ and KJW were funded by the Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe). The Dr. Senckenberg Institute of Neurooncology is supported by the Dr. Senckenberg Foundation. MS is funded through a Postdoctoral Fellowship provided by the Dr. Rurainski Foundation for Cancer Research.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>KJW and MS conceptualized and designed the study. KJW, MD, ES, ID, MM, and MS acquired data. KJW, PSZ, PNH, and MS analyzed and interpreted the data. KJW wrote the manuscript and prepared figures and tables with input and critical revision from all authors. All authors read, reviewed, and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by Projekt DEAL. Deutsche Krebshilfe, Dr. Rurainski Foundation for Cancer Research.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data relevant to the study, analyzed and/or generated within this study are included in the article or uploaded as supplementary information. All other data and raw data IDAT files will be made accessible upon reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Conflict of Interest</h3>
<p id="Par35">The authors declare that there are no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Appay R, Dehais C, Maurage C-A, Alentorn A, Carpentier C, Colin C et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol. 10.1093/neuonc/noz124
</cite> [<a href="https://doi.org/10.1093/neuonc/noz124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7145561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31832685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Appay%20R,%20Dehais%20C,%20Maurage%20C-A,%20Alentorn%20A,%20Carpentier%20C,%20Colin%20C%20et%20al%20(2019)%20CDKN2A%20homozygous%20deletion%20is%20a%20strong%20adverse%20prognosis%20factor%20in%20diffuse%20malignant%20IDH-mutant%20gliomas.%20Neuro%20Oncol.%2010.1093/neuonc/noz124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Aran D, Sirota M, Butte AJ (2015) Systematic pan-cancer analysis of tumour purity. Nat Commun 6:8971. 10.1038/ncomms9971
</cite> [<a href="https://doi.org/10.1038/ncomms9971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4671203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26634437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aran%20D,%20Sirota%20M,%20Butte%20AJ%20(2015)%20Systematic%20pan-cancer%20analysis%20of%20tumour%20purity.%20Nat%20Commun%206:8971.%2010.1038/ncomms9971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Bady P, Marosi C, Weller M, Grønberg BH, Schultz H, Taphoorn MJB et al (2022) DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients. Acta Neuropathol Commun 10:39. 10.1186/s40478-022-01344-5
</cite> [<a href="https://doi.org/10.1186/s40478-022-01344-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8944086/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35331339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bady%20P,%20Marosi%20C,%20Weller%20M,%20Gr%C3%B8nberg%20BH,%20Schultz%20H,%20Taphoorn%20MJB%20et%20al%20(2022)%20DNA%20methylation-based%20age%20acceleration%20observed%20in%20IDH%20wild-type%20glioblastoma%20is%20associated%20with%20better%20outcome%E2%80%94including%20in%20elderly%20patients.%20Acta%20Neuropathol%20Commun%2010:39.%2010.1186/s40478-022-01344-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112–120. 10.1038/s41586-019-1775-1
</cite> [<a href="https://doi.org/10.1038/s41586-019-1775-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6897368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31748746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barthel%20FP,%20Johnson%20KC,%20Varn%20FS,%20Moskalik%20AD,%20Tanner%20G,%20Kocakavuk%20E%20et%20al%20(2019)%20Longitudinal%20molecular%20trajectories%20of%20diffuse%20glioma%20in%20adults.%20Nature%20576:112%E2%80%93120.%2010.1038/s41586-019-1775-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Cakmak P, Jurmeister P, Divé I, Zeiner PS, Steinbach JP, Fenton TR et al (2024) DNA methylation-based analysis reveals accelerated epigenetic aging in giant cell-enriched adult-type glioblastoma. Clin Epigenetics 16:179. 10.1186/s13148-024-01793-w
</cite> [<a href="https://doi.org/10.1186/s13148-024-01793-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11636044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39663543/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cakmak%20P,%20Jurmeister%20P,%20Div%C3%A9%20I,%20Zeiner%20PS,%20Steinbach%20JP,%20Fenton%20TR%20et%20al%20(2024)%20DNA%20methylation-based%20analysis%20reveals%20accelerated%20epigenetic%20aging%20in%20giant%20cell-enriched%20adult-type%20glioblastoma.%20Clin%20Epigenetics%2016:179.%2010.1186/s13148-024-01793-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. 10.1038/nature26000
</cite> [<a href="https://doi.org/10.1038/nature26000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6093218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29539639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Capper%20D,%20Jones%20DTW,%20Sill%20M,%20Hovestadt%20V,%20Schrimpf%20D,%20Sturm%20D%20et%20al%20(2018)%20DNA%20methylation-based%20classification%20of%20central%20nervous%20system%20tumours.%20Nature%20555:469%E2%80%93474.%2010.1038/nature26000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA et al (2016) Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164:550–563. 10.1016/j.cell.2015.12.028
</cite> [<a href="https://doi.org/10.1016/j.cell.2015.12.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4754110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26824661/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ceccarelli%20M,%20Barthel%20FP,%20Malta%20TM,%20Sabedot%20TS,%20Salama%20SR,%20Murray%20BA%20et%20al%20(2016)%20Molecular%20profiling%20reveals%20biologically%20discrete%20subsets%20and%20pathways%20of%20progression%20in%20diffuse%20glioma.%20Cell%20164:550%E2%80%93563.%2010.1016/j.cell.2015.12.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Chakravarthy A, Furness A, Joshi K, Ghorani E, Ford K, Ward MJ et al (2018) Pan-cancer deconvolution of tumour composition using DNA methylation. Nat Commun. 10.1038/s41467-018-05570-1
</cite> [<a href="https://doi.org/10.1038/s41467-018-05570-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6089972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30104673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chakravarthy%20A,%20Furness%20A,%20Joshi%20K,%20Ghorani%20E,%20Ford%20K,%20Ward%20MJ%20et%20al%20(2018)%20Pan-cancer%20deconvolution%20of%20tumour%20composition%20using%20DNA%20methylation.%20Nat%20Commun.%2010.1038/s41467-018-05570-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Cimino PJ, Zager M, McFerrin L, Wirsching H-G, Bolouri H, Hentschel B et al (2017) Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Acta Neuropathol Commun 5:39. 10.1186/s40478-017-0443-7
</cite> [<a href="https://doi.org/10.1186/s40478-017-0443-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5439117/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28532485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cimino%20PJ,%20Zager%20M,%20McFerrin%20L,%20Wirsching%20H-G,%20Bolouri%20H,%20Hentschel%20B%20et%20al%20(2017)%20Multidimensional%20scaling%20of%20diffuse%20gliomas:%20application%20to%20the%202016%20World%20Health%20Organization%20classification%20system%20with%20prognostically%20relevant%20molecular%20subtype%20discovery.%20Acta%20Neuropathol%20Commun%205:39.%2010.1186/s40478-017-0443-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ et al (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:21931–21936. 10.1073/pnas.1016071107
</cite> [<a href="https://doi.org/10.1073/pnas.1016071107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3003124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21106759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Creyghton%20MP,%20Cheng%20AW,%20Welstead%20GG,%20Kooistra%20T,%20Carey%20BW,%20Steine%20EJ%20et%20al%20(2010)%20Histone%20H3K27ac%20separates%20active%20from%20poised%20enhancers%20and%20predicts%20developmental%20state.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%20107:21931%E2%80%9321936.%2010.1073/pnas.1016071107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Figarella-Branger D, Colin C, Mokhtari K, Uro-Coste E, Idbaih A, Appay R et al (2024) Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: lessons from the French POLA cohort. Neuro Oncol. 10.1093/neuonc/noae221
</cite> [<a href="https://doi.org/10.1093/neuonc/noae221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11889709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39432559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Figarella-Branger%20D,%20Colin%20C,%20Mokhtari%20K,%20Uro-Coste%20E,%20Idbaih%20A,%20Appay%20R%20et%20al%20(2024)%20Reappraisal%20of%20prognostic%20factors%20in%20CNS%20WHO%20grade%203%20oligodendrogliomas%20IDH-mutant%20and%201p/19q%20co-deleted:%20lessons%20from%20the%20French%20POLA%20cohort.%20Neuro%20Oncol.%2010.1093/neuonc/noae221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Figarella-Branger D, Mokhtari K, Dehais C, Carpentier C, Colin C, Jouvet A et al (2016) Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas. Neuro Oncol 18:888–890. 10.1093/neuonc/now085
</cite> [<a href="https://doi.org/10.1093/neuonc/now085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4864268/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27175000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Figarella-Branger%20D,%20Mokhtari%20K,%20Dehais%20C,%20Carpentier%20C,%20Colin%20C,%20Jouvet%20A%20et%20al%20(2016)%20Mitotic%20index,%20microvascular%20proliferation,%20and%20necrosis%20define%203%20pathological%20subgroups%20of%20prognostic%20relevance%20among%201p/19q%20co-deleted%20anaplastic%20oligodendrogliomas.%20Neuro%20Oncol%2018:888%E2%80%93890.%2010.1093/neuonc/now085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A et al (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:553–567. 10.1016/j.ccr.2010.11.015
</cite> [<a href="https://doi.org/10.1016/j.ccr.2010.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4105845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21130701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Figueroa%20ME,%20Abdel-Wahab%20O,%20Lu%20C,%20Ward%20PS,%20Patel%20J,%20Shih%20A%20et%20al%20(2010)%20Leukemic%20IDH1%20and%20IDH2%20mutations%20result%20in%20a%20hypermethylation%20phenotype,%20disrupt%20TET2%20function,%20and%20impair%20hematopoietic%20differentiation.%20Cancer%20Cell%2018:553%E2%80%93567.%2010.1016/j.ccr.2010.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Filipski K, Scherer M, Zeiner KN, Bucher A, Kleemann J, Jurmeister P et al (2021) DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma. J Immunother Cancer 9:1–11. 10.1136/jitc-2020-002226</cite> [<a href="https://doi.org/10.1136/jitc-2020-002226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8291310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34281986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Filipski%20K,%20Scherer%20M,%20Zeiner%20KN,%20Bucher%20A,%20Kleemann%20J,%20Jurmeister%20P%20et%20al%20(2021)%20DNA%20methylation-based%20prediction%20of%20response%20to%20immune%20checkpoint%20inhibition%20in%20metastatic%20melanoma.%20J%20Immunother%20Cancer%209:1%E2%80%9311.%2010.1136/jitc-2020-002226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ghisai SA, van Hijfte L, Vallentgoed WR, Tesileanu CMS, de Heer I, Kros JM et al (2024) Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma. Acta Neuropathol 148:50. 10.1007/s00401-024-02811-0
</cite> [<a href="https://doi.org/10.1007/s00401-024-02811-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11464554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39382765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghisai%20SA,%20van%20Hijfte%20L,%20Vallentgoed%20WR,%20Tesileanu%20CMS,%20de%20Heer%20I,%20Kros%20JM%20et%20al%20(2024)%20Epigenetic%20landscape%20reorganisation%20and%20reactivation%20of%20embryonic%20development%20genes%20are%20associated%20with%20malignancy%20in%20IDH-mutant%20astrocytoma.%20Acta%20Neuropathol%20148:50.%2010.1007/s00401-024-02811-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S et al (2001) Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:248–262. 10.1093/jnen/60.3.248
</cite> [<a href="https://doi.org/10.1093/jnen/60.3.248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11245209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giannini%20C,%20Scheithauer%20BW,%20Weaver%20AL,%20Burger%20PC,%20Kros%20JM,%20Mork%20S%20et%20al%20(2001)%20Oligodendrogliomas:%20reproducibility%20and%20prognostic%20value%20of%20histologic%20diagnosis%20and%20grading.%20J%20Neuropathol%20Exp%20Neurol%2060:248%E2%80%93262.%2010.1093/jnen/60.3.248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Grabovska Y, Mackay A, O’Hare P, Crosier S, Finetti M, Schwalbe EC et al (2020) Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity. Nat Commun 11:4324. 10.1038/s41467-020-18070-y
</cite> [<a href="https://doi.org/10.1038/s41467-020-18070-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7455736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32859926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grabovska%20Y,%20Mackay%20A,%20O%E2%80%99Hare%20P,%20Crosier%20S,%20Finetti%20M,%20Schwalbe%20EC%20et%20al%20(2020)%20Pediatric%20pan-central%20nervous%20system%20tumor%20analysis%20of%20immune-cell%20infiltration%20identifies%20correlates%20of%20antitumor%20immunity.%20Nat%20Commun%2011:4324.%2010.1038/s41467-020-18070-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14:R115. 10.1186/gb-2013-14-10-r115
</cite> [<a href="https://doi.org/10.1186/gb-2013-14-10-r115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4015143/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24138928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horvath%20S%20(2013)%20DNA%20methylation%20age%20of%20human%20tissues%20and%20cell%20types.%20Genome%20Biol%2014:R115.%2010.1186/gb-2013-14-10-r115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Ippen FM, Hielscher T, Friedel D, Göbel K, Reuss D, Herold-Mende C et al (2025) The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma. Neuro Oncol 27(3):743–754. 10.1093/neuonc/noae238
</cite> [<a href="https://doi.org/10.1093/neuonc/noae238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11889711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39530475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ippen%20FM,%20Hielscher%20T,%20Friedel%20D,%20G%C3%B6bel%20K,%20Reuss%20D,%20Herold-Mende%20C%20et%20al%20(2025)%20The%20prognostic%20impact%20of%20CDKN2A/B%20hemizygous%20deletions%20in%20IDH-mutant%20glioma.%20Neuro%20Oncol%2027(3):743%E2%80%93754.%2010.1093/neuonc/noae238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Jaunmuktane Z, Capper D, Jones DTW, Schrimpf D, Sill M, Dutt M et al (2019) Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Commun 7:24. 10.1186/s40478-019-0668-8
</cite> [<a href="https://doi.org/10.1186/s40478-019-0668-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6381711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30786920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jaunmuktane%20Z,%20Capper%20D,%20Jones%20DTW,%20Schrimpf%20D,%20Sill%20M,%20Dutt%20M%20et%20al%20(2019)%20Methylation%20array%20profiling%20of%20adult%20brain%20tumours:%20diagnostic%20outcomes%20in%20a%20large,%20single%20centre.%20Acta%20Neuropathol%20Commun%207:24.%2010.1186/s40478-019-0668-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Kumar D, Cinghu S, Oldfield AJ, Yang P, Jothi R (2021) Decoding the function of bivalent chromatin in development and cancer. Genome Res 31:2170–2184. 10.1101/gr.275736.121
</cite> [<a href="https://doi.org/10.1101/gr.275736.121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8647824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34667120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumar%20D,%20Cinghu%20S,%20Oldfield%20AJ,%20Yang%20P,%20Jothi%20R%20(2021)%20Decoding%20the%20function%20of%20bivalent%20chromatin%20in%20development%20and%20cancer.%20Genome%20Res%2031:2170%E2%80%932184.%2010.1101/gr.275736.121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Liao P, Ostrom QT, Stetson L, Barnholtz-Sloan JS (2018) Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence. Neuro Oncol 20:942–953. 10.1093/neuonc/noy003
</cite> [<a href="https://doi.org/10.1093/neuonc/noy003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6007761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29432558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liao%20P,%20Ostrom%20QT,%20Stetson%20L,%20Barnholtz-Sloan%20JS%20(2018)%20Models%20of%20epigenetic%20age%20capture%20patterns%20of%20DNA%20methylation%20in%20glioma%20associated%20with%20molecular%20subtype,%20survival,%20and%20recurrence.%20Neuro%20Oncol%2020:942%E2%80%93953.%2010.1093/neuonc/noy003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. 10.1093/neuonc/noab106
</cite> [<a href="https://doi.org/10.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34185076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Louis%20DN,%20Perry%20A,%20Wesseling%20P,%20Brat%20DJ,%20Cree%20IA,%20Figarella-Branger%20D%20et%20al%20(2021)%20The%202021%20WHO%20classification%20of%20tumors%20of%20the%20central%20nervous%20system:%20a%20summary.%20Neuro%20Oncol%2023:1231%E2%80%931251.%2010.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Lu Y, Cao Q, Yu Y, Sun Y, Jiang X, Li X (2023) Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications. BMC Genomics 24:235. 10.1186/s12864-023-09341-1
</cite> [<a href="https://doi.org/10.1186/s12864-023-09341-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10157937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37138231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20Y,%20Cao%20Q,%20Yu%20Y,%20Sun%20Y,%20Jiang%20X,%20Li%20X%20(2023)%20Pan-cancer%20analysis%20revealed%20H3K4me1%20at%20bivalent%20promoters%20premarks%20DNA%20hypermethylation%20during%20tumor%20development%20and%20identified%20the%20regulatory%20role%20of%20DNA%20methylation%20in%20relation%20to%20histone%20modifications.%20BMC%20Genomics%2024:235.%2010.1186/s12864-023-09341-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Lutsik P, Slawski M, Gasparoni G, Vedeneev N, Hein M, Walter J (2017) MeDeCom: discovery and quantification of latent components of heterogeneous methylomes. Genome Biol 18:55. 10.1186/s13059-017-1182-6
</cite> [<a href="https://doi.org/10.1186/s13059-017-1182-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5366155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28340624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lutsik%20P,%20Slawski%20M,%20Gasparoni%20G,%20Vedeneev%20N,%20Hein%20M,%20Walter%20J%20(2017)%20MeDeCom:%20discovery%20and%20quantification%20of%20latent%20components%20of%20heterogeneous%20methylomes.%20Genome%20Biol%2018:55.%2010.1186/s13059-017-1182-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Markouli M, Strepkos D, Papavassiliou KA, Papavassiliou AG, Piperi C (2021) Bivalent genes targeting of glioma heterogeneity and plasticity. Int J Mol Sci 22:540. 10.3390/ijms22020540
</cite> [<a href="https://doi.org/10.3390/ijms22020540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7826605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33430434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Markouli%20M,%20Strepkos%20D,%20Papavassiliou%20KA,%20Papavassiliou%20AG,%20Piperi%20C%20(2021)%20Bivalent%20genes%20targeting%20of%20glioma%20heterogeneity%20and%20plasticity.%20Int%20J%20Mol%20Sci%2022:540.%2010.3390/ijms22020540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J et al (2023) Vorasidenib in <em>IDH1</em>- or <em>IDH2</em>-mutant low-grade glioma. N Engl J Med 389:589–601. 10.1056/NEJMoa2304194
</cite> [<a href="https://doi.org/10.1056/NEJMoa2304194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11445763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37272516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mellinghoff%20IK,%20van%20den%20Bent%20MJ,%20Blumenthal%20DT,%20Touat%20M,%20Peters%20KB,%20Clarke%20J%20et%20al%20(2023)%20Vorasidenib%20in%20IDH1-%20or%20IDH2-mutant%20low-grade%20glioma.%20N%20Engl%20J%20Med%20389:589%E2%80%93601.%2010.1056/NEJMoa2304194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Müller F, Scherer M, Assenov Y, Lutsik P, Walter J, Lengauer T et al (2019) RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol 20:55. 10.1186/s13059-019-1664-9
</cite> [<a href="https://doi.org/10.1186/s13059-019-1664-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6419383/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30871603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?M%C3%BCller%20F,%20Scherer%20M,%20Assenov%20Y,%20Lutsik%20P,%20Walter%20J,%20Lengauer%20T%20et%20al%20(2019)%20RnBeads%202.0:%20comprehensive%20analysis%20of%20DNA%20methylation%20data.%20Genome%20Biol%2020:55.%2010.1186/s13059-019-1664-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mur P, Mollejo M, Ruano Y, de Lope ÁR, Fiaño C, García JF et al (2013) Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors. Acta Neuropathol 126:277–289. 10.1007/s00401-013-1130-9
</cite> [<a href="https://doi.org/10.1007/s00401-013-1130-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23689617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mur%20P,%20Mollejo%20M,%20Ruano%20Y,%20de%20Lope%20%C3%81R,%20Fia%C3%B1o%20C,%20Garc%C3%ADa%20JF%20et%20al%20(2013)%20Codeletion%20of%201p%20and%2019q%20determines%20distinct%20gene%20methylation%20and%20expression%20profiles%20in%20IDH-mutated%20oligodendroglial%20tumors.%20Acta%20Neuropathol%20126:277%E2%80%93289.%2010.1007/s00401-013-1130-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453–457. 10.1038/nmeth.3337
</cite> [<a href="https://doi.org/10.1038/nmeth.3337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25822800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Newman%20AM,%20Liu%20CL,%20Green%20MR,%20Gentles%20AJ,%20Feng%20W,%20Xu%20Y%20et%20al%20(2015)%20Robust%20enumeration%20of%20cell%20subsets%20from%20tissue%20expression%20profiles.%20Nat%20Methods%2012:453%E2%80%93457.%2010.1038/nmeth.3337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP et al (2010) Identification of a CpG Island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510–522. 10.1016/j.ccr.2010.03.017
</cite> [<a href="https://doi.org/10.1016/j.ccr.2010.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2872684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20399149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Noushmehr%20H,%20Weisenberger%20DJ,%20Diefes%20K,%20Phillips%20HS,%20Pujara%20K,%20Berman%20BP%20et%20al%20(2010)%20Identification%20of%20a%20CpG%20Island%20methylator%20phenotype%20that%20defines%20a%20distinct%20subgroup%20of%20glioma.%20Cancer%20Cell%2017:510%E2%80%93522.%2010.1016/j.ccr.2010.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C et al (2023) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol 25:iv1–iv99. 10.1093/neuonc/noad149
</cite> [<a href="https://doi.org/10.1093/neuonc/noad149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10550277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37793125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ostrom%20QT,%20Price%20M,%20Neff%20C,%20Cioffi%20G,%20Waite%20KA,%20Kruchko%20C%20et%20al%20(2023)%20CBTRUS%20statistical%20report:%20primary%20brain%20and%20other%20central%20nervous%20system%20tumors%20diagnosed%20in%20the%20United%20States%20in%202016%E2%80%932020.%20Neuro%20Oncol%2025:iv1%E2%80%93iv99.%2010.1093/neuonc/noad149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC (2013) A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 14:293. 10.1186/1471-2164-14-293
</cite> [<a href="https://doi.org/10.1186/1471-2164-14-293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3769145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23631413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pidsley%20R,%20Y%20Wong%20CC,%20Volta%20M,%20Lunnon%20K,%20Mill%20J,%20Schalkwyk%20LC%20(2013)%20A%20data-driven%20approach%20to%20preprocessing%20Illumina%20450K%20methylation%20array%20data.%20BMC%20Genomics%2014:293.%2010.1186/1471-2164-14-293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Scherer M, Nazarov PV, Toth R, Sahay S, Kaoma T, Maurer V et al (2020) Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz. Nat Protoc 15:3240–3263. 10.1038/s41596-020-0369-6
</cite> [<a href="https://doi.org/10.1038/s41596-020-0369-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32978601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scherer%20M,%20Nazarov%20PV,%20Toth%20R,%20Sahay%20S,%20Kaoma%20T,%20Maurer%20V%20et%20al%20(2020)%20Reference-free%20deconvolution,%20visualization%20and%20interpretation%20of%20complex%20DNA%20methylation%20data%20using%20DecompPipeline,%20MeDeCom%20and%20FactorViz.%20Nat%20Protoc%2015:3240%E2%80%933263.%2010.1038/s41596-020-0369-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F et al (2018) Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol 136:153–166. 10.1007/s00401-018-1849-4
</cite> [<a href="https://doi.org/10.1007/s00401-018-1849-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29687258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shirahata%20M,%20Ono%20T,%20Stichel%20D,%20Schrimpf%20D,%20Reuss%20DE,%20Sahm%20F%20et%20al%20(2018)%20Novel,%20improved%20grading%20system(s)%20for%20IDH-mutant%20astrocytic%20gliomas.%20Acta%20Neuropathol%20136:153%E2%80%93166.%2010.1007/s00401-018-1849-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>de Souza CF, Sabedot TS, Malta TM, Stetson L, Morozova O, Sokolov A et al (2018) A distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence. Cell Rep 23:637–651. 10.1016/j.celrep.2018.03.107
</cite> [<a href="https://doi.org/10.1016/j.celrep.2018.03.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8859991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29642018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Souza%20CF,%20Sabedot%20TS,%20Malta%20TM,%20Stetson%20L,%20Morozova%20O,%20Sokolov%20A%20et%20al%20(2018)%20A%20distinct%20DNA%20methylation%20shift%20in%20a%20subset%20of%20glioma%20CpG%20island%20methylator%20phenotypes%20during%20tumor%20recurrence.%20Cell%20Rep%2023:637%E2%80%93651.%2010.1016/j.celrep.2018.03.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E et al (2012) <em>IDH1</em> mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:479–483. 10.1038/nature10866
</cite> [<a href="https://doi.org/10.1038/nature10866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3351699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22343889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Turcan%20S,%20Rohle%20D,%20Goenka%20A,%20Walsh%20LA,%20Fang%20F,%20Yilmaz%20E%20et%20al%20(2012)%20IDH1%20mutation%20is%20sufficient%20to%20establish%20the%20glioma%20hypermethylator%20phenotype.%20Nature%20483:479%E2%80%93483.%2010.1038/nature10866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Vu H, Ernst J (2022) Universal annotation of the human genome through integration of over a thousand epigenomic datasets. Genome Biol 23:9. 10.1186/s13059-021-02572-z
</cite> [<a href="https://doi.org/10.1186/s13059-021-02572-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8734071/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34991667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vu%20H,%20Ernst%20J%20(2022)%20Universal%20annotation%20of%20the%20human%20genome%20through%20integration%20of%20over%20a%20thousand%20epigenomic%20datasets.%20Genome%20Biol%2023:9.%2010.1186/s13059-021-02572-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C et al (2007) Epigenetic stem cell signature in cancer. Nat Genet 39:157–158. 10.1038/ng1941
</cite> [<a href="https://doi.org/10.1038/ng1941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17200673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Widschwendter%20M,%20Fiegl%20H,%20Egle%20D,%20Mueller-Holzner%20E,%20Spizzo%20G,%20Marth%20C%20et%20al%20(2007)%20Epigenetic%20stem%20cell%20signature%20in%20cancer.%20Nat%20Genet%2039:157%E2%80%93158.%2010.1038/ng1941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim S-H et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30. 10.1016/j.ccr.2010.12.014
</cite> [<a href="https://doi.org/10.1016/j.ccr.2010.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3229304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21251613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20W,%20Yang%20H,%20Liu%20Y,%20Yang%20Y,%20Wang%20P,%20Kim%20S-H%20et%20al%20(2011)%20Oncometabolite%202-hydroxyglutarate%20is%20a%20competitive%20inhibitor%20of%20%CE%B1-ketoglutarate-dependent%20dioxygenases.%20Cancer%20Cell%2019:17%E2%80%9330.%2010.1016/j.ccr.2010.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Yu Y, Li X, Jiao R, Lu Y, Jiang X, Li X (2023) H3K27me3-H3K4me1 transition at bivalent promoters instructs lineage specification in development. Cell Biosci 13:66. 10.1186/s13578-023-01017-3
</cite> [<a href="https://doi.org/10.1186/s13578-023-01017-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10061859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36991495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20Y,%20Li%20X,%20Jiao%20R,%20Lu%20Y,%20Jiang%20X,%20Li%20X%20(2023)%20H3K27me3-H3K4me1%20transition%20at%20bivalent%20promoters%20instructs%20lineage%20specification%20in%20development.%20Cell%20Biosci%2013:66.%2010.1186/s13578-023-01017-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Zheng C, Berger NA, Li L, Xu R (2020) Epigenetic age acceleration and clinical outcomes in gliomas. PLoS ONE 15:e0236045. 10.1371/journal.pone.0236045
</cite> [<a href="https://doi.org/10.1371/journal.pone.0236045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7373289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32692766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20C,%20Berger%20NA,%20Li%20L,%20Xu%20R%20(2020)%20Epigenetic%20age%20acceleration%20and%20clinical%20outcomes%20in%20gliomas.%20PLoS%20ONE%2015:e0236045.%2010.1371/journal.pone.0236045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374884/bin/401_2025_2926_MOESM1_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (XLSX 66 KB)</a><sup> (65.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374884/bin/401_2025_2926_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file2 (DOCX 1174 KB)</a><sup> (1.1MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data relevant to the study, analyzed and/or generated within this study are included in the article or uploaded as supplementary information. All other data and raw data IDAT files will be made accessible upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Acta Neuropathologica are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s00401-025-02926-y"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/401_2025_Article_2926.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374884/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374884/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374884%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374884/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374884/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374884/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849395/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374884/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849395/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374884/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374884/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="eJbZZLAi5HeeUwTFrnzkktofFpUgojUzqS9udaGWqzFeb1Ef2jpJfVM95GxnsSj9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
